Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group
Athanasios G. Galanopoulos, Department of Clinical Hematology, ‘G. Gennimatas’ Hospital, 154 Mesogion Street, 11527 Athens, Greece
Tel/Fax: +30 210 7470473
No abstract is available for this article.